HEMP Stock Overview
Hempalta Corp., an agricultural cleantech company, produces and processes industrial hemp in North America.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Hempalta Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.19 |
| 52 Week High | CA$0.30 |
| 52 Week Low | CA$0.068 |
| Beta | 0.14 |
| 1 Month Change | -9.52% |
| 3 Month Change | n/a |
| 1 Year Change | 59.67% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -45.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| HEMP | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -2.6% | -3.6% | 0.7% |
| 1Y | 59.7% | 54.7% | 5.5% |
Return vs Industry: HEMP exceeded the Canadian Pharmaceuticals industry which returned 53% over the past year.
Return vs Market: HEMP exceeded the Canadian Market which returned 6.1% over the past year.
Price Volatility
| HEMP volatility | |
|---|---|
| HEMP Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 13.8% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.2% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: HEMP has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HEMP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 14 | Darren Bondar | www.hempalta.com |
Hempalta Corp., an agricultural cleantech company, produces and processes industrial hemp in North America. It manufactures products using a process known as HempTrain that enables to produce a range of hemp-based commercial and consumer products. The company also engages in the hemp carbon credit market.
Hempalta Corp. Fundamentals Summary
| HEMP fundamental statistics | |
|---|---|
| Market cap | CA$15.66m |
| Earnings (TTM) | -CA$1.94m |
| Revenue (TTM) | CA$457.54k |
34.2x
P/S Ratio-8.1x
P/E RatioIs HEMP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HEMP income statement (TTM) | |
|---|---|
| Revenue | CA$457.54k |
| Cost of Revenue | CA$671.43k |
| Gross Profit | -CA$213.89k |
| Other Expenses | CA$1.73m |
| Earnings | -CA$1.94m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.024 |
| Gross Margin | -46.75% |
| Net Profit Margin | -424.65% |
| Debt/Equity Ratio | 116.1% |
How did HEMP perform over the long term?
See historical performance and comparison